Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector

Bioconjugate Chemistry

Volumn 19, Issue 10, 2008, Pages 2040-2048

  Abd Elgaliel, Wael R ^a   Gallazzi, Fabio ^a   Garrison, Jered C ^b,c   Rold, Tammy L ^b,c   Sieckman, Gary L ^b,c   Figueroa, Said Daibes ^b,c   Hoffman, Timothy J ^a,b,c   Lever, Susan Z ^a,d  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d 125 Chemistry Bldg   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM COMPOUNDS; BAYESIAN NETWORKS; BINDING ENERGY; CELL CULTURE; CELLS; DISEASES; MAMMALS; UROLOGY;

BINDING AFFINITIES; BIOLOGICAL EVALUATION; BOMBESIN ANALOGUES; CANCER CELL LINES; DESIGN EVALUATION; DESIGN SYNTHESIS; PANCREAS CELLS; PEPTIDE RECEPTOR; SYNTHESIS EVALUATION; TUMOR CELL LINES;

TUMORS;

BOMBESIN DERIVATIVE; BOMPROAMIDE IN 111; DEMOBESIN 1; GASTRIN RELEASING PEPTIDE RECEPTOR; INDIUM 111; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DESIGN; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INTERNALIZATION; ISOTOPE LABELING; MOUSE; NONHUMAN; SCID MOUSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

MUS;

EID: 55249096687     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800290c     Document Type: Article

References (41)

1. Anastasi, A., Erspamer, V., and Bucci, M. (1971) Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27, 166-7.
2. McDonald, T. J., Jornvall, H., Nilsson, G., Vag-Bloom, S. R., and Mutt, V. (1979) Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem. Biophys. Commun. 90, 227-233.
3. Ohki-Hamazaki, H., Iwabuchi, M., and Maekawa, F. (2005) Development and function of bombesin-like peptides and their receptors. Int. J. Dev. Biol. 49, 293-300.
4. Reubi, J. C., and Waser, B. (2003) Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting. Eur. J. Nucl. Med. Mol. Imaging 30, 781-93.
5. Reubi, J. C., Korner, M., Waser, B., Mazzucchelli, L., and Guillou, L. (2004) High expression of peptide receptors as a novel target in gastrointestinal stomal tumours. Eur. J. Nucl. Med. Mol. Imaging 31, 803-10.
6. Reubi, J. C., Gugger, M., and Waser, B. (2002) Co-expressed peptide receptors in breast cancers as molecular basis for in vivo multireceptor tumor targeting. Eur. J. Nucl. Med. Mol. Imaging 29, 855-862.
7. Darker, J. G., Brough, S. J., Heath, J., and Smart, D. (2001) Discovery of potent and selective peptide agonists at the GRP-preferring bombesin receptor (BB2). J. Pept. Sci. 7, 598-605.
8. Fleischmann, A., Laderach, U., Friess, H., Buechler, M. W., and Reubi, J. C. (2000) Bombesin receptors in distinct tissue compartments of human pancreatic diseases. Lab. Invest. 80, 1807-1817.
9. Reubi, J. C. (1995) In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging. J. Nucl. Med. 36, 1846-1853.
10. Rogers, B. E., Parry, J. J., Andrews, R., Cordopatis, P., Nock, B. A., and Maina, T. (1889) (2005) MicroPET imaging of gene transfer with a somatostatin receptor-based reporter gene and (94m)Tc-Demotate 1. J. Nucl. Med. 46 97.
11. Reubi, J. C. (1995) Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging. J. Nucl. Med. 36, 1825-1835.
12. Van de Wiele, C., Dumont, F., Vanden Broecke, R., Oosterlinck, W., Cocquyt, V., Serreyn, R., Peers, S., Thornback, J., Slegers, G., and Dierckx, R. A. (2000) Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study. Eur. J. Nucl. Med. 27, 1694-9.
13. Zhang, H., Chen, J., Waldherr, C., Hinni, K., Waser, B., Reubi, J. C., and Maecke, H. R. (2004) Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors. Cancer Res. 64, 6707-15.
14. Lin, K. S., Luu, A., Baidoo, K. E., Hashemzadeh-Gargari, H., Chen, M. K., Brenneman, K., Pili, R., Pomper, M., Carducci, M. A., and Wagner, H. N., Jr. (2005) A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation. Bioconjugate Chem. 16, 43-50.
15. Nock, B. A., Nikolopoulou, A., Galanis, A., Cordopatis, P., Waser, B., Reubi, J. C., and Maina, T. (2005) Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study. J. Med. Chem. 48, 100-10.
16. 177Lu-AMBA. Eur. J. Nucl. Med. Mol. Imaging 34, 95-100.
17. Zhang, H., Schuhmacher, J., Waser, B., Wild, D., Eisenhut, M., Reubi, J. C., and Maecke, H. R. (2007) DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours. Eur. J. Nucl. Med. Mol. Imaging 34, 1198-208.
18. 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems. J. Nucl. Med. 48, 1327-37.
19. 111In-labelled bombesin analogues for molecular imaging of prostate tumours. Eur. J. Nucl. Med. Mol. Imaging 34, 1228-38.
20. Maina, T., Nock, B., and Mather, S. (2006) Targeting prostate cancer with radiolabelled bombesins. Cancer Imaging 6, 153-7.
21. Ma, L., Yu, P., Veerendra, B., Rold, T. L., Retzloff, L., Prasanphanich, A., Sieckman, G., Hoffman, T. J., Volkert, W. A., and Smith, C. J. (2007) In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor. Mol. Imaging 6, 171-80.
22. 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. J. Nucl. Med. 47, 1144-52.
23. 3. Cancer Res. 63, 4082-8.
24. Perrin, M. H., Sutton, S. W., Cervini, L. A., Rivier, J. E., and Vale, W. W. (1999) Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J. Pharmacol. Exp. Ther. 288, 729-34.
25. 2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues. Proc. Natl. Acad. Sci. U.S.A. 104, 12462-7.
26. 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. J. Nucl. Med. 44, 823-31.
27. Wang, L. H., Coy, D. H., Taylor, J. E., Jiang, N. Y., Moreau, J. P., Huang, S. C., Frucht, H., Haffar, B. M., and Jensen, R. T. (1990) des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. J. Biol. Chem. 265, 15695-703.
28. Coy, D. H., Taylor, J. E., Jiang, N. Y., Kim, S. H., Wang, L. H., Huang, S. C., Moreau, J. P., Gardner, J. D., and Jensen, R. T. (1989) Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. J. Biol. Chem. 264, 14691-7.
29. Sleight, A. J., Stam, N. J., Mutel, V., and Vanderheyden, P. M. (1996) Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities. Biochem. Pharmacol. 51, 71-6.
30. Cescato, R., Maina, T., Nock, B., Nikolopoulou, A., Charalambidis, D., Piccand, V., and Reubi, J. C. (2008) Bombesin receptor antagonists may be preferable to agonists for tumor targeting. J. Nucl. Med. 49, 318-26.
31. Ginj, M., Zhang, H., Waser, B., Cescato, R., Wild, D., Wang, X., Erchegyi, J., Rivier, J., Macke, H. R., and Reubi, J. C. (2006) Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Proc. Natl. Acad. Sci. U.S.A. 103, 16436-41.
32. Coy, D. H., Jensen, R. T., Jiang, N. Y., Lin, J. T., Bogden, A. E., and Moreau, J. P. (1992) Systematic development of bombesin/gastrin-releasing peptide antagonists. J. Natl. Cancer Inst. Monogr. 133-9.
33. 99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging. Eur. J. Nucl. Med. Mol. Imaging 30, 247-58.
34. Abd-Elgaliel, W. R., Gallazzi, F., and Lever, S. Z. (2007) Total solid-phase synthesis of bombesin analogs with different functional groups at the C-terminus. J. Pept. Sci. 13, 487-92.
35. Lister-James, J., Moyer, B. R., and Dean, R. T. (1997) Pharmacokinetic considerations in the development of peptide-based imaging agents. Q. J. Nucl. Med. 41, 111-8.
36. Arano, Y. (1998) Strategies to reduce renal radioactivity levels of antibody fragments. Q. J. Nucl. Med. 42, 262-70.
37. Gonzalez, N., Moody, T. W., Igarashi, H., Ito, T., and Jensen, R. T. (2007) Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr. Opin. Endocrinol. Diabetes Obes. 15, 58-64.
38. Vauquelin, G., and Van Liefde, I. (2006) Slow antagonist dissociation and long-lasting in vivo receptor protection. Trends Pharmacol. Sci. 27, 356-9.
39. Pelosi, G., Volante, M., Papotti, M., Sonzogni, A., Masullo, M., and Viale, G. (2006) Peptide receptors in neuroendocrine tumors of the lung as potential tools for radionuclide diagnosis and therapy. Q. J. Nucl. Med. Mol. Imaging 50, 272-87.
40. Corjay, M. H., Dobrzanski, D. J., Way, J. M., Viallet, J., Shapira, H., Worland, P., Sausville, E. A., and Battey, J. F. (1991) Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. Biol. Chem. 266, 18771-18779.
41. Hohla, F., Schally, A. V., Kanashiro, C. A., Buchholz, S., Baker, B., Kannadka, C., Moder, A., Aigner, E., Datz, C., and Halmos, G. (2007) Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt. Proc. Natl. Acad. Sci. U.S.A. 104, 18671-6.